Back to results
US 2026/0306616 A1Published application
Spike Protein Based Genetic Vaccines
AssigneeUniversity of Maryland, Baltimore
InventorsSyed Saif Hasan, Suruchi Singh
Life of this patent
Estimating the term…
Abstract
Provided herein are genetic vaccines and immunogenic constructs and methods of use effective to elicit immune responses against a coronavirus. The genetic vaccines and immunogenic constructs encode or comprise coronaviral spike tail peptides with one or two substitutions in the coatomer dibasic motif. Also provided are plasmids constructed to produce mRNAs for use in the genetic vaccines.
Claims19
An immunogenic construct, comprising:
- a coronavirus spike protein with at least one substitution therein.
A plasmid, comprising:
- a nucleic acid sequence that encodes an mRNA for a mutated coronavirus spike;
- and
- a promoter operably linked to the nucleic acid sequence that regulates expression of the mRNA.
A genetic vaccine, comprising:
- a mRNA that encodes a mutated spike protein, wherein said protein, when produced in a recipient of the vaccine, elicits a protective immune response against a coronavirus.
A genetic vaccine directed against a severe acute respiratory coronavirus 2, comprising:
- a mRNA that encodes a mutated spike protein with a sequence comprising GVALAYT (SEQ ID NO:
- 2) or GVKLKYT (SEQ ID NO:
- 3) or a combination thereof.
Dependencies are inferred from the claim text.